The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brillia...
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
John Carreyrou is a two-time Pulitzer Prize-winning investigative reporter at The Wall Street Journal. For his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism in the category of beat reporting, and the Barlett & Steele Silver Award for Investigative Bus...
John Carreyrou is a two-time Pulitzer Prize-winning investigative reporter at The Wall Street Journal. For his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism in the category of beat reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. Carreyrou lives in Brooklyn with his wife and three children.
For the dozens of Indians Theranos employed, the fear of being fired was more than just the dread of losing a paycheck. Most were on H-1B visas and dependent on their continued employment at the company to remain in the country. With a despotic boss like Sunny holding their fates in his hands, it was akin to indentured servitude. (查看原文)
开头铺得还不错，感觉像是个豪门浪女，后来发现就是个三代破落户。后面陷入了反复攻击同一问题的鬼打墙，找了几十个人来作证Sunny和Elizabeth的管理近乎恐吓暴政，然后产品不完善的情况下到处兜售。对于为什么有名望的旧贵族、市场份额巨大的药企买Theranos的诡计，统统归咎于小妞的个人说服力和低沉的嗓音（小妞具体说了什么又没调查到），这就很滑稽了。我看了她好几个采访，这个女的其实语言效率极其低，...开头铺得还不错，感觉像是个豪门浪女，后来发现就是个三代破落户。后面陷入了反复攻击同一问题的鬼打墙，找了几十个人来作证Sunny和Elizabeth的管理近乎恐吓暴政，然后产品不完善的情况下到处兜售。对于为什么有名望的旧贵族、市场份额巨大的药企买Theranos的诡计，统统归咎于小妞的个人说服力和低沉的嗓音（小妞具体说了什么又没调查到），这就很滑稽了。我看了她好几个采访，这个女的其实语言效率极其低，逻辑也不算好。 是什么魅力让她真的说服大家去接受一个半吊子产品？ 美元上印着 in god we trust，还是要深挖一下，为什么这些人怕被 missed out, 他们相信这个小妞背后其实在相信什么？ 比较二流吧。传记作家和调查记者都是靠写作对象活的，你不是真正的爱她的是畏惧她我觉得还是不配拿普(展开)
Elizabeth Holmes Theranos founder. Henry Mosley Theranos Chief Financial Officer (CFO). Donald L. Lucas Chairman of the board. Former Ventural Capitalist. Channing Robertson On the Board of Directors. Associate Dean at Stanford. Ramesh "Sunny" Balwani Gary ...
(展开)
I still remembered searching WIPO for Theranos's patents and FDA establishment registration back in 2015, and was disappointed to find that there's little evidence that this company was worth 9 billion. I've been since following the Theranos's downfall, whi...
(展开)
timeregister
北京联合出版公司2019版
curious Sam
Picador2018版
Ms Cellophane
zhifeige
28 有用 Albatross 2018-05-25 14:34:13
集硅谷startup反面案例之大成，终于出版了。一晚上啃一半，爱不释手
13 有用 理性批判 2018-12-01 15:23:53
2018年快读完毕，没读的人不必读了。大表姐的电影会来了。简单说，就是不创新的科技骗子+一帮恶棍律师事务所，竟然能够在美国将这个骗局掩盖了这么多年。George总统的孙子去做实习生发现了大问题，保持自己的良心，竟然还能被恶棍律师恶意闭嘴。简直就牛上天了！2018年11月正好是，基因编辑儿童在中国被广泛讨论，看来所谓的“科技狂人”由商业和资本的刺激之下，以后还是会层出不穷的。
116 有用 狐梨酱 2018-12-04 14:50:09
一个令人抑郁的故事。本书最大的问题是它在前半部试图以上帝视角来讲述这个故事，但Carreyron并没有足够的信息来做这个上帝。因此前半部给我最大的感觉就是我产生的疑问全都得不到解答，在Carreyron开始用第一人称讲述这个故事之后就好了很多（我怀疑前半部是不是为了增加书的厚度，编辑要求他后来加上的）。Carreyron把Theranos多年成功的最大原因归结于Holmes的个人魅力。我不买这个帐... 一个令人抑郁的故事。本书最大的问题是它在前半部试图以上帝视角来讲述这个故事，但Carreyron并没有足够的信息来做这个上帝。因此前半部给我最大的感觉就是我产生的疑问全都得不到解答，在Carreyron开始用第一人称讲述这个故事之后就好了很多（我怀疑前半部是不是为了增加书的厚度，编辑要求他后来加上的）。Carreyron把Theranos多年成功的最大原因归结于Holmes的个人魅力。我不买这个帐。这也是我最大的疑问。Carreyron没能给我一个回答，很可惜也没办法知道更多。在我粗浅的理解中，Holmes昙花一现的“成功”充分展示了所谓elitists，或者说“上层阶级”的盲从与愚蠢。恐怕也正是这种愚蠢和其产生的严重后果才造成了今天世界的割裂和populism explosion。三星半。 (展开)
25 有用 shibuya emiri 2018-12-17 12:33:14
开头铺得还不错，感觉像是个豪门浪女，后来发现就是个三代破落户。后面陷入了反复攻击同一问题的鬼打墙，找了几十个人来作证Sunny和Elizabeth的管理近乎恐吓暴政，然后产品不完善的情况下到处兜售。对于为什么有名望的旧贵族、市场份额巨大的药企买Theranos的诡计，统统归咎于小妞的个人说服力和低沉的嗓音（小妞具体说了什么又没调查到），这就很滑稽了。我看了她好几个采访，这个女的其实语言效率极其低，... 开头铺得还不错，感觉像是个豪门浪女，后来发现就是个三代破落户。后面陷入了反复攻击同一问题的鬼打墙，找了几十个人来作证Sunny和Elizabeth的管理近乎恐吓暴政，然后产品不完善的情况下到处兜售。对于为什么有名望的旧贵族、市场份额巨大的药企买Theranos的诡计，统统归咎于小妞的个人说服力和低沉的嗓音（小妞具体说了什么又没调查到），这就很滑稽了。我看了她好几个采访，这个女的其实语言效率极其低，逻辑也不算好。 是什么魅力让她真的说服大家去接受一个半吊子产品？ 美元上印着 in god we trust，还是要深挖一下，为什么这些人怕被 missed out, 他们相信这个小妞背后其实在相信什么？ 比较二流吧。传记作家和调查记者都是靠写作对象活的，你不是真正的爱她的是畏惧她我觉得还是不配拿普 (展开)
209 有用 Nausikaa 2018-12-21 14:14:16
Bill Gates推荐Bad Blood一定是想让大家都来看看死对头David Boies的丑事。
0 有用 须弥山论客 2024-07-12 09:07:09 湖北
可读性不错。
0 有用 hhhhhhh 2024-06-30 22:15:50 广东
Theranos完全是"fake it until you make it"的绝佳反面案例。。。 作者让我体会到记者这个职业的伟大之处，很好的一本书，很有启发意义，respect🫡
0 有用 霓裳 2024-06-22 10:22:50 山东
各种角度的无法理解 我甚至觉得东亚的骗子们应该走出去开辟新天地了
0 有用 zhang xian 2024-06-18 03:24:58 美国
居然是Michigan Engineering Common Reading Experience的书单之一
0 有用 吃瓜群众000 2024-05-30 10:45:47 美国
太精彩太好看太匪夷所思了！ “fake it until you make it” 这种硅谷文化用在医疗界就是灾难！ 幸亏还有调查记者这个行业揭发黑内幕，不然不知道有多少病人受害。